APO Research
Talk to an analyst

APO RESEARCH · REPORT

Aciclovir Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Aciclovir Drug Industry Growth and Trends Forecast to 2032

20 December 2025102 pages

Choose your research edition.

Industry ResearchAciclovir Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Aciclovir Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Aciclovir Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aciclovir Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Aciclovir Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Aciclovir Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Aciclovir Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Aciclovir Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Aciclovir Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Aciclovir Drug include Yiling Pharmaceutical, SHANGHAI CP GENERAL PHARMACEUTICAL, UNITED LABORATOR IES, Kangzheng Pharmaceutical, Fresenius Kabi, Zydus Pharmaceuticals, Vectans Pharma, Talent Healthcare and RelonChem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Aciclovir Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Aciclovir Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Aciclovir Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Aciclovir Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Aciclovir Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Aciclovir Drug Market by Company

Yiling Pharmaceutical

SHANGHAI CP GENERAL PHARMACEUTICAL

UNITED LABORATOR IES

Kangzheng Pharmaceutical

Fresenius Kabi

Zydus Pharmaceuticals

Vectans Pharma

Talent Healthcare

RelonChem

Novus Life Sciences

Cipla

Blue Pharma

Actiza Pharma

Aciclovir Drug Segment by Type

Topical Ointment

Oral Tablet

Lntravenous Dosage Forms

Aciclovir Drug Segment by Application

Shingles

Herpes Simplex Virus Infection

Chickenpox in Immunocompromised Persons

Others

Aciclovir Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aciclovir Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aciclovir Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aciclovir Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Aciclovir Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Aciclovir Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Topical Ointment Table 2. Major Company of Oral Tablet Table 3. Major Company of Lntravenous Dosage Forms Table 4. Global Aciclovir Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Aciclovir Drug Sales by Type (2021-2026) & (K Units) Table 6. Global Aciclovir Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Aciclovir Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Aciclovir Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Aciclovir Drug Price by Type (2021-2026) & (US$/Unit) Table 10. Global Aciclovir Drug Sales by Type (2027-2032) & (K Units) Table 11. Global Aciclovir Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Aciclovir Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Aciclovir Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Aciclovir Drug Price by Type (2027-2032) & (US$/Unit) Table 15. North America Aciclovir Drug Sales by Type (2021-2026) & (K Units) Table 16. North America Aciclovir Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Aciclovir Drug Sales by Type (2021-2026) & (K Units) Table 18. Europe Aciclovir Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Aciclovir Drug Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Aciclovir Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Aciclovir Drug Sales by Type (2021-2026) & (K Units) Table 22. Latin America Aciclovir Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Aciclovir Drug Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Aciclovir Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Aciclovir Drug Industry Trends Table 26. Aciclovir Drug Industry Drivers Table 27. Aciclovir Drug Industry Opportunities and Challenges Table 28. Aciclovir Drug Industry Restraints Table 29. Global Aciclovir Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Aciclovir Drug Revenue Market Share by Company (2021-2026) Table 31. Global Aciclovir Drug Sales by Company (2021-2026) & (K Units) Table 32. Global Aciclovir Drug Sales Share by Company (2021-2026) Table 33. Global Aciclovir Drug Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Aciclovir Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Aciclovir Drug Major Company Production Sites and Headquarters Table 36. Global Aciclovir Drug Company, Product Type & Application Table 37. Global Aciclovir Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Aciclovir Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Aciclovir Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Aciclovir Drug Sales by Region (2021-2026) & (K Units) Table 42. Global Aciclovir Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Aciclovir Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Aciclovir Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Aciclovir Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Aciclovir Drug Sales by Region (2027-2032) & (K Units) Table 47. Global Aciclovir Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Aciclovir Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Aciclovir Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Aciclovir Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Aciclovir Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Aciclovir Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Aciclovir Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Aciclovir Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Aciclovir Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Aciclovir Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Aciclovir Drug Sales by Application (2027-2032) & (K Units) Table 58. Global Aciclovir Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Aciclovir Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Aciclovir Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Aciclovir Drug Price by Application (2027-2032) & (US$/Unit) Table 62. North America Aciclovir Drug Sales by Application (2021-2026) & (K Units) Table 63. North America Aciclovir Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Aciclovir Drug Sales by Application (2021-2026) & (K Units) Table 65. Europe Aciclovir Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Aciclovir Drug Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Aciclovir Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Aciclovir Drug Sales by Application (2021-2026) & (K Units) Table 69. Latin America Aciclovir Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Aciclovir Drug Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Aciclovir Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Yiling Pharmaceutical Company Information Table 73. Yiling Pharmaceutical Business Overview Table 74. Yiling Pharmaceutical Aciclovir Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Yiling Pharmaceutical Aciclovir Drug Product Portfolio Table 76. Yiling Pharmaceutical Recent Development Table 77. SHANGHAI CP GENERAL PHARMACEUTICAL Company Information Table 78. SHANGHAI CP GENERAL PHARMACEUTICAL Business Overview Table 79. SHANGHAI CP GENERAL PHARMACEUTICAL Aciclovir Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. SHANGHAI CP GENERAL PHARMACEUTICAL Aciclovir Drug Product Portfolio Table 81. SHANGHAI CP GENERAL PHARMACEUTICAL Recent Development Table 82. UNITED LABORATOR IES Company Information Table 83. UNITED LABORATOR IES Business Overview Table 84. UNITED LABORATOR IES Aciclovir Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. UNITED LABORATOR IES Aciclovir Drug Product Portfolio Table 86. UNITED LABORATOR IES Recent Development Table 87. Kangzheng Pharmaceutical Company Information Table 88. Kangzheng Pharmaceutical Business Overview Table 89. Kangzheng Pharmaceutical Aciclovir Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Kangzheng Pharmaceutical Aciclovir Drug Product Portfolio Table 91. Kangzheng Pharmaceutical Recent Development Table 92. Fresenius Kabi Company Information Table 93. Fresenius Kabi Business Overview Table 94. Fresenius Kabi Aciclovir Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Fresenius Kabi Aciclovir Drug Product Portfolio Table 96. Fresenius Kabi Recent Development Table 97. Zydus Pharmaceuticals Company Information Table 98. Zydus Pharmaceuticals Business Overview Table 99. Zydus Pharmaceuticals Aciclovir Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Zydus Pharmaceuticals Aciclovir Drug Product Portfolio Table 101. Zydus Pharmaceuticals Recent Development Table 102. Vectans Pharma Company Information Table 103. Vectans Pharma Business Overview Table 104. Vectans Pharma Aciclovir Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Vectans Pharma Aciclovir Drug Product Portfolio Table 106. Vectans Pharma Recent Development Table 107. Talent Healthcare Company Information Table 108. Talent Healthcare Business Overview Table 109. Talent Healthcare Aciclovir Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Talent Healthcare Aciclovir Drug Product Portfolio Table 111. Talent Healthcare Recent Development Table 112. RelonChem Company Information Table 113. RelonChem Business Overview Table 114. RelonChem Aciclovir Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. RelonChem Aciclovir Drug Product Portfolio Table 116. RelonChem Recent Development Table 117. Novus Life Sciences Company Information Table 118. Novus Life Sciences Business Overview Table 119. Novus Life Sciences Aciclovir Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Novus Life Sciences Aciclovir Drug Product Portfolio Table 121. Novus Life Sciences Recent Development Table 122. Cipla Company Information Table 123. Cipla Business Overview Table 124. Cipla Aciclovir Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Cipla Aciclovir Drug Product Portfolio Table 126. Cipla Recent Development Table 127. Blue Pharma Company Information Table 128. Blue Pharma Business Overview Table 129. Blue Pharma Aciclovir Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Blue Pharma Aciclovir Drug Product Portfolio Table 131. Blue Pharma Recent Development Table 132. Actiza Pharma Company Information Table 133. Actiza Pharma Business Overview Table 134. Actiza Pharma Aciclovir Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Actiza Pharma Aciclovir Drug Product Portfolio Table 136. Actiza Pharma Recent Development Table 137. North America Aciclovir Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. North America Aciclovir Drug Sales by Country (2021-2026) & (K Units) Table 139. North America Aciclovir Drug Sales Market Share by Country (2021-2026) Table 140. North America Aciclovir Drug Sales Forecast by Country (2027-2032) & (K Units) Table 141. North America Aciclovir Drug Sales Market Share Forecast by Country (2027-2032) Table 142. North America Aciclovir Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Aciclovir Drug Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Aciclovir Drug Market Share by Country (2021-2026) Table 145. North America Aciclovir Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Aciclovir Drug Market Share Forecast by Country (2027-2032) Table 147. Europe Aciclovir Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Europe Aciclovir Drug Sales by Country (2021-2026) & (K Units) Table 149. Europe Aciclovir Drug Sales Market Share by Country (2021-2026) Table 150. Europe Aciclovir Drug Sales Forecast by Country (2027-2032) & (K Units) Table 151. Europe Aciclovir Drug Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Aciclovir Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Aciclovir Drug Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Aciclovir Drug Market Share by Country (2021-2026) Table 155. Europe Aciclovir Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Aciclovir Drug Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Aciclovir Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Aciclovir Drug Sales by Country (2021-2026) & (K Units) Table 159. Asia-Pacific Aciclovir Drug Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Aciclovir Drug Sales Forecast by Country (2027-2032) & (K Units) Table 161. Asia-Pacific Aciclovir Drug Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Aciclovir Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Aciclovir Drug Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Aciclovir Drug Market Share by Country (2021-2026) Table 165. Asia-Pacific Aciclovir Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Aciclovir Drug Market Share Forecast by Country (2027-2032) Table 167. Latin America Aciclovir Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Latin America Aciclovir Drug Sales by Country (2021-2026) & (K Units) Table 169. Latin America Aciclovir Drug Sales Market Share by Country (2021-2026) Table 170. Latin America Aciclovir Drug Sales Forecast by Country (2027-2032) & (K Units) Table 171. Latin America Aciclovir Drug Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Aciclovir Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Aciclovir Drug Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Aciclovir Drug Market Share by Country (2021-2026) Table 175. Latin America Aciclovir Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Aciclovir Drug Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Aciclovir Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Aciclovir Drug Sales by Country (2021-2026) & (K Units) Table 179. Middle East and Africa Aciclovir Drug Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Aciclovir Drug Sales Forecast by Country (2027-2032) & (K Units) Table 181. Middle East and Africa Aciclovir Drug Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Aciclovir Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Aciclovir Drug Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Aciclovir Drug Market Share by Country (2021-2026) Table 185. Middle East and Africa Aciclovir Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Aciclovir Drug Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Aciclovir Drug Distributors List Table 190. Aciclovir Drug Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Aciclovir Drug Image Figure 2. Global Aciclovir Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aciclovir Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Aciclovir Drug Sales (2021-2032) & (K Units) Figure 5. Topical Ointment Image Figure 6. Global Topical Ointment Sales YoY Growth (2021-2032) & (K Units) Figure 7. Oral Tablet Image Figure 8. Global Oral Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. Lntravenous Dosage Forms Image Figure 10. Global Lntravenous Dosage Forms Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Aciclovir Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Aciclovir Drug Market Share by Type 2025 VS 2032 Figure 13. North America Aciclovir Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Aciclovir Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Aciclovir Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Aciclovir Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Aciclovir Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Aciclovir Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Aciclovir Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Aciclovir Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Aciclovir Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Aciclovir Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Aciclovir Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Shingles Image Figure 26. Global Shingles Sales YoY Growth (2021-2032) & (K Units) Figure 27. Herpes Simplex Virus Infection Image Figure 28. Global Herpes Simplex Virus Infection Sales YoY Growth (2021-2032) & (K Units) Figure 29. Chickenpox in Immunocompromised Persons Image Figure 30. Global Chickenpox in Immunocompromised Persons Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Aciclovir Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Aciclovir Drug Market Share by Application 2025 VS 2032 Figure 35. North America Aciclovir Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Aciclovir Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Aciclovir Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Aciclovir Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Aciclovir Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Aciclovir Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Aciclovir Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Aciclovir Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Aciclovir Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Aciclovir Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Aciclovir Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Aciclovir Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Aciclovir Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Aciclovir Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Aciclovir Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Aciclovir Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Aciclovir Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Aciclovir Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Aciclovir Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Aciclovir Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Aciclovir Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Aciclovir Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Aciclovir Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Aciclovir Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Aciclovir Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Aciclovir Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Aciclovir Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Aciclovir Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Aciclovir Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Aciclovir Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Aciclovir Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Aciclovir Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Topical Ointment
  • Oral Tablet
  • Lntravenous Dosage Forms
Applications
  • Shingles
  • Herpes Simplex Virus Infection
  • Chickenpox in Immunocompromised Persons
  • Others
Companies covered
  • Yiling Pharmaceutical
  • SHANGHAI CP GENERAL PHARMACEUTICAL
  • UNITED LABORATOR IES
  • Kangzheng Pharmaceutical
  • Fresenius Kabi
  • Zydus Pharmaceuticals
  • Vectans Pharma
  • Talent Healthcare
  • RelonChem
  • Novus Life Sciences
  • Cipla
  • Blue Pharma
  • Actiza Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Aciclovir Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Aciclovir Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Aciclovir Drug Market by Type
  6. 1.3.1 Topical Ointment
  7. 1.3.2 Oral Tablet
  8. 1.3.3 Lntravenous Dosage Forms
  9. 1.4 Global Aciclovir Drug Market Size by Type
  10. 1.4.1 Global Aciclovir Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Aciclovir Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Aciclovir Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Aciclovir Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Aciclovir Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Aciclovir Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Aciclovir Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Aciclovir Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Aciclovir Drug Industry Trends
  2. 2.2 Aciclovir Drug Industry Drivers
  3. 2.3 Aciclovir Drug Industry Opportunities and Challenges
  4. 2.4 Aciclovir Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Aciclovir Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Aciclovir Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Aciclovir Drug Price (2021-2026)
  4. 3.4 Global Aciclovir Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Aciclovir Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Aciclovir Drug Company, Product Type & Application
  7. 3.7 Global Aciclovir Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Aciclovir Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Aciclovir Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Aciclovir Drug Tier 1, Tier 2, and Tier 3
4 Aciclovir Drug Regional Status and Outlook
  1. 4.1 Global Aciclovir Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Aciclovir Drug Historic Market Size by Region
  3. 4.2.1 Global Aciclovir Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Aciclovir Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Aciclovir Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Aciclovir Drug Forecasted Market Size by Region
  7. 4.3.1 Global Aciclovir Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Aciclovir Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Aciclovir Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Aciclovir Drug by Application
  1. 5.1 Aciclovir Drug Market by Application
  2. 5.1.1 Shingles
  3. 5.1.2 Herpes Simplex Virus Infection
  4. 5.1.3 Chickenpox in Immunocompromised Persons
  5. 5.1.4 Others
  6. 5.2 Global Aciclovir Drug Market Size by Application
  7. 5.2.1 Global Aciclovir Drug Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Aciclovir Drug Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Aciclovir Drug Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Aciclovir Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Aciclovir Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Aciclovir Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Aciclovir Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Aciclovir Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yiling Pharmaceutical
  2. 6.1.1 Yiling Pharmaceutical Company Information
  3. 6.1.2 Yiling Pharmaceutical Business Overview
  4. 6.1.3 Yiling Pharmaceutical Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yiling Pharmaceutical Aciclovir Drug Product Portfolio
  6. 6.1.5 Yiling Pharmaceutical Recent Developments
  7. 6.2 SHANGHAI CP GENERAL PHARMACEUTICAL
  8. 6.2.1 SHANGHAI CP GENERAL PHARMACEUTICAL Company Information
  9. 6.2.2 SHANGHAI CP GENERAL PHARMACEUTICAL Business Overview
  10. 6.2.3 SHANGHAI CP GENERAL PHARMACEUTICAL Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 SHANGHAI CP GENERAL PHARMACEUTICAL Aciclovir Drug Product Portfolio
  12. 6.2.5 SHANGHAI CP GENERAL PHARMACEUTICAL Recent Developments
  13. 6.3 UNITED LABORATOR IES
  14. 6.3.1 UNITED LABORATOR IES Company Information
  15. 6.3.2 UNITED LABORATOR IES Business Overview
  16. 6.3.3 UNITED LABORATOR IES Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 UNITED LABORATOR IES Aciclovir Drug Product Portfolio
  18. 6.3.5 UNITED LABORATOR IES Recent Developments
  19. 6.4 Kangzheng Pharmaceutical
  20. 6.4.1 Kangzheng Pharmaceutical Company Information
  21. 6.4.2 Kangzheng Pharmaceutical Business Overview
  22. 6.4.3 Kangzheng Pharmaceutical Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Kangzheng Pharmaceutical Aciclovir Drug Product Portfolio
  24. 6.4.5 Kangzheng Pharmaceutical Recent Developments
  25. 6.5 Fresenius Kabi
  26. 6.5.1 Fresenius Kabi Company Information
  27. 6.5.2 Fresenius Kabi Business Overview
  28. 6.5.3 Fresenius Kabi Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Fresenius Kabi Aciclovir Drug Product Portfolio
  30. 6.5.5 Fresenius Kabi Recent Developments
  31. 6.6 Zydus Pharmaceuticals
  32. 6.6.1 Zydus Pharmaceuticals Company Information
  33. 6.6.2 Zydus Pharmaceuticals Business Overview
  34. 6.6.3 Zydus Pharmaceuticals Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Zydus Pharmaceuticals Aciclovir Drug Product Portfolio
  36. 6.6.5 Zydus Pharmaceuticals Recent Developments
  37. 6.7 Vectans Pharma
  38. 6.7.1 Vectans Pharma Company Information
  39. 6.7.2 Vectans Pharma Business Overview
  40. 6.7.3 Vectans Pharma Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Vectans Pharma Aciclovir Drug Product Portfolio
  42. 6.7.5 Vectans Pharma Recent Developments
  43. 6.8 Talent Healthcare
  44. 6.8.1 Talent Healthcare Company Information
  45. 6.8.2 Talent Healthcare Business Overview
  46. 6.8.3 Talent Healthcare Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Talent Healthcare Aciclovir Drug Product Portfolio
  48. 6.8.5 Talent Healthcare Recent Developments
  49. 6.9 RelonChem
  50. 6.9.1 RelonChem Company Information
  51. 6.9.2 RelonChem Business Overview
  52. 6.9.3 RelonChem Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 RelonChem Aciclovir Drug Product Portfolio
  54. 6.9.5 RelonChem Recent Developments
  55. 6.10 Novus Life Sciences
  56. 6.10.1 Novus Life Sciences Company Information
  57. 6.10.2 Novus Life Sciences Business Overview
  58. 6.10.3 Novus Life Sciences Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novus Life Sciences Aciclovir Drug Product Portfolio
  60. 6.10.5 Novus Life Sciences Recent Developments
  61. 6.11 Cipla
  62. 6.11.1 Cipla Company Information
  63. 6.11.2 Cipla Business Overview
  64. 6.11.3 Cipla Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Cipla Aciclovir Drug Product Portfolio
  66. 6.11.5 Cipla Recent Developments
  67. 6.12 Blue Pharma
  68. 6.12.1 Blue Pharma Company Information
  69. 6.12.2 Blue Pharma Business Overview
  70. 6.12.3 Blue Pharma Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Blue Pharma Aciclovir Drug Product Portfolio
  72. 6.12.5 Blue Pharma Recent Developments
  73. 6.13 Actiza Pharma
  74. 6.13.1 Actiza Pharma Company Information
  75. 6.13.2 Actiza Pharma Business Overview
  76. 6.13.3 Actiza Pharma Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Actiza Pharma Aciclovir Drug Product Portfolio
  78. 6.13.5 Actiza Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Aciclovir Drug Sales by Country
  2. 7.1.1 North America Aciclovir Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Aciclovir Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Aciclovir Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Aciclovir Drug Market Size by Country
  6. 7.2.1 North America Aciclovir Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Aciclovir Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Aciclovir Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Aciclovir Drug Sales by Country
  2. 8.1.1 Europe Aciclovir Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Aciclovir Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Aciclovir Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Aciclovir Drug Market Size by Country
  6. 8.2.1 Europe Aciclovir Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Aciclovir Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Aciclovir Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Aciclovir Drug Sales by Country
  2. 9.1.1 Asia-Pacific Aciclovir Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Aciclovir Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Aciclovir Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Aciclovir Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Aciclovir Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Aciclovir Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Aciclovir Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Aciclovir Drug Sales by Country
  2. 10.1.1 South America Aciclovir Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Aciclovir Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Aciclovir Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Aciclovir Drug Market Size by Country
  6. 10.2.1 South America Aciclovir Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Aciclovir Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Aciclovir Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Aciclovir Drug Sales by Country
  2. 11.1.1 Middle East and Africa Aciclovir Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Aciclovir Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Aciclovir Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Aciclovir Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Aciclovir Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Aciclovir Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Aciclovir Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Aciclovir Drug Value Chain Analysis
  2. 12.1.1 Aciclovir Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Aciclovir Drug Production Mode & Process
  7. 12.2 Aciclovir Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Aciclovir Drug Distributors
  10. 12.2.3 Aciclovir Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst